#New York #Class Action #US #PepGen Inc #PEPG

The Gross Law Firm and PepGen Inc. Class Action

The Gross Law Firm has recently informed shareholders of PepGen Inc. (NASDAQ: PEPG) about the filing of a securities class action. This action is aimed at protecting the interests of investors who acquired shares during the defined class period, which spans from March 7, 2024, to March 3, 2025. The firm invites affected shareholders to come forward and register their participation in the class action lawsuit.

Allegations Against PepGen

The basis of the class action involves serious allegations against PepGen, suggesting that the company misled investors regarding the effectiveness and safety of its lead product candidate, PGN-EDO51. The complaint stipulates that the defendants failed to disclose crucial information about the phase two CONNECT2 study. Specifically, it is alleged that this study was either dangerous or otherwise deficient, placing its validity for U.S. Food and Drug Administration (FDA) approval in jeopardy. Consequently, the overstatements regarding PGN-EDO51's clinical, regulatory, and commercial viability have been called into question, leading to an inflated perception of the company's stock and its offerings.

Understanding the Class Period

Shareholders who acquired shares of PepGen within the specified timeframe are strongly encouraged to reach out to The Gross Law Firm. By doing so, individuals may be eligible for various forms of recovery stemming from the lawsuit. Importantly, the appointment as a lead plaintiff—positioning an investor to potentially spearhead the case—is not a requirement for participation or recovery in the action.

As the deadline for registering as a lead plaintiff approaches on August 8, 2025, shareholders should not hesitate; registration ensures that they are kept informed through a portfolio monitoring service, providing updates throughout the legal process.

In light of these allegations, the firm is committed to safeguarding the rights of all investors affected by potentially deceptive practices. The Gross Law Firm's mission revolves around holding companies accountable for misleading statements that could adversely affect their stock value and, consequently, investors’ portfolios.

Next Steps for Interested Shareholders

For shareholders concerned about their investments in PepGen, the next critical step is to register through the provided link. This action does not incur any fees or obligations for those affected. It provides peace of mind knowing that they will have access to comprehensive updates and status reports regarding the progression of the lawsuit.

The Gross Law Firm has established itself with a robust reputation in class action litigation, promising dedication and thoroughness in seeking justice for investors who have faced financial losses due to misrepresentation and fraud. As a recognized leader in this field, the firm aims to ensure that responsible business practices are upheld and all stakeholders can engage in fair investing.

Contact Information for The Gross Law Firm

For further inquiries, please contact The Gross Law Firm at their New York office:

• - Address: 15 West 38th Street, 12th floor, New York, NY 10018
• - Phone: (646) 453-8903
• - Email: [email protected]

Conclusion

Investors in PepGen Inc. have encountered a pivotal moment where collective action could lead to compensation for potential financial losses. Registering for this class action not only empowers individual shareholders but reinforces the importance of accountability in the financial markets.